Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cardiovascular & Hematological Disorders Drug Targets|January 5, 2010
CD44 - a new cardiovascular drug target or merely an innocent bystander?Alexandra Krettek, Sara SjöbergClinical Reviews in Bone and Mineral Metabolism|April 17, 2012
Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic AneurysmSara Sjöberg, Guo-Ping ShiMetabolism: Clinical and Experimental|February 4, 2005
Circulating soluble CD44 is higher among women than men and is not associated with cardiovascular risk factors or subclinical atherosclerosisSara Sjöberg, Linda Fogelstrand, Johannes Hulthe, et al.Endocrinology|April 21, 2007
The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient miceJohan Bourghardt, Göran Bergström, Alexandra Krettek, et al.International Journal of Cancer|February 22, 2002
CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer riskHaixin Lei, Sara Sjöberg-Margolin, Sima Salahshor, et al.Atherosclerosis|April 7, 2009
CD44-deficiency on hematopoietic cells limits T-cell number but does not protect against atherogenesis in LDL receptor-deficient miceSara Sjöberg, Einar E Eriksson, Asa Tivesten, et al.Atherosclerosis|July 25, 2013
Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient miceJing Wang, Sara Sjöberg, Viviane Tia, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2011
Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in miceJiusong Sun, Galina K Sukhova, Jie Zhang, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 27, 2011
Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in miceJiusong Sun, Galina K Sukhova, Jie Zhang, et al.Pageof 2